These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21159128)

  • 21. [Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation].
    Jung BY; Lee SH; Chung SK; Lee CK; Lee TH; Chung IK; Kim SJ; Cho HD
    Korean J Gastroenterol; 2012 Jun; 59(6):437-40. PubMed ID: 22735878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone.
    Kemmler N; Pfannschmidt N; Strohal R
    Acta Derm Venereol; 2012 Jul; 92(4):406-7. PubMed ID: 22113308
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C; Calado J; Cravo M
    BioDrugs; 2010 Dec; 24 Suppl 1():15-7. PubMed ID: 21175229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.
    Verburg R; Zelissen P; Rothova A; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2008 Oct; 14(10):1457-60. PubMed ID: 18383178
    [No Abstract]   [Full Text] [Related]  

  • 25. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
    Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC; Nielsen AM
    Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
    Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
    Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
    Lopez-Sanroman A; Gisbert JP
    Aliment Pharmacol Ther; 2012 Sep; 36(5):498-9. PubMed ID: 22860615
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice?
    Tursi A; Elisei W; Picchio M; Penna A
    Aliment Pharmacol Ther; 2013 Apr; 37(7):763-4. PubMed ID: 23458543
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease.
    Fries W; La Malfa G; Costantino G; Repici A; Mazziotti S; Navarra G
    Inflamm Bowel Dis; 2011 Feb; 17(2):671-3. PubMed ID: 20848472
    [No Abstract]   [Full Text] [Related]  

  • 32. Onset of severe perianal disease in Crohn's disease under treatment with infliximab: successful treatment with adalimumab and setons drainage.
    Tursi A; Papa A; Maiorano M
    Inflamm Bowel Dis; 2011 Feb; 17(2):676-8. PubMed ID: 20848475
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid recovery of a rectovaginal fistula with infliximab in a patient with Crohn's disease.
    Hagiu C; Badea R; Serban A; Petrar S; Andreica V
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):329-32. PubMed ID: 20922201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of postoperative recurrence of Crohn's disease by infliximab.
    Sorrentino D; Terrosu G; Avellini C; Beltrami CA; Bresadola V; Toso F
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):457-9. PubMed ID: 16538123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
    Kinney T; Rawlins M; Kozarek R; France R; Patterson D
    Am J Gastroenterol; 2003 Mar; 98(3):608-12. PubMed ID: 12650795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory polypoid mass treated with Infliximab in a Crohn's disease patient.
    Liatsos C; Kyriakos N; Panagou E; Karagiannis S; Salemis N; Mavrogiannis C
    J Crohns Colitis; 2010 Dec; 4(6):707-8. PubMed ID: 21122587
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment-resistant lingual Crohn's disease disappears after infliximab.
    Brunner B; Hirschi C; Weimann R; Seibold F
    Scand J Gastroenterol; 2005 Oct; 40(10):1255-9. PubMed ID: 16265783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism and therapeutic strategy of second failure of infliximab treatment for Crohn's disease].
    Kanai T; Matsuoka K; Hisamatsu T; Iwao Y; Ogata H; Hibi T
    Nihon Shokakibyo Gakkai Zasshi; 2012 Mar; 109(3):364-9. PubMed ID: 22398900
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis by EUS trucut biopsy of extrapulmonary tuberculosis in a patient with Crohn's disease treated with infliximab.
    Gleeson F; Clarke E; Kelly S; Hargadan G; Kenny E; MacMathuna P; Lennon J
    Gastrointest Endosc; 2005 Mar; 61(3):489-92. PubMed ID: 15758934
    [No Abstract]   [Full Text] [Related]  

  • 40. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
    Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
    Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.